Bo Xi1, Jie Mi. 1. Graduate School, Peking Union Medical College, Beijing 100730, China. swei006@163.com
Abstract
OBJECTIVE: To clarify the contradictory findings in patients with obesity and type 2 diabetes by meta-analysis. METHODS: PubMed and Embase were searched for articles published up to March 2009. All studies on the association of FTO polymorphisms with obesity and type 2 diabetes were included. Pooled odds ratio was calculated using the model of fixed or random effects. Sensitivity analysis was performed to evaluate the stability of meta-analytic results. RESULTS: Meta-analysis suggested that rs9939609 A allele was more significantly associated with obesity risk than T allele (3 studies / 004 cases and 4544 control subjects): random effect odds ratio (OR)=1.28, 95%CI=1.05 and 1.55, P heterogeneity =0.05, I2=66.6%. Similar results were observed in rs8050136 polymorphism (3 studies/2404 cases and 5713 control subjects): fixed effect OR =1.25, 95%CI=1.13, 1.37, P heterogeneity=0.12, I2=51.9%. However, no significant association was found between genetics and risk of type 2 diabetes after control of potential confounders (at least for BMI) either for rs9939609 (fixed effect OR=1.05, 95% CI=0.97,1.13) or for rs8050136 polymorphism (fixed effect OR =1.07, 95%CI: 0.99, 1.16). Furthermore, the sensitivity analysis strengthened our confidence in validity of the association. Conclusion FTO polymorphisms are associated with obesity but not with type 2 diabetes in East Asian populations. Further large-scale studies are required to conclusively establish the association.
OBJECTIVE: To clarify the contradictory findings in patients with obesity and type 2 diabetes by meta-analysis. METHODS: PubMed and Embase were searched for articles published up to March 2009. All studies on the association of FTO polymorphisms with obesity and type 2 diabetes were included. Pooled odds ratio was calculated using the model of fixed or random effects. Sensitivity analysis was performed to evaluate the stability of meta-analytic results. RESULTS: Meta-analysis suggested that rs9939609 A allele was more significantly associated with obesity risk than T allele (3 studies / 004 cases and 4544 control subjects): random effect odds ratio (OR)=1.28, 95%CI=1.05 and 1.55, P heterogeneity =0.05, I2=66.6%. Similar results were observed in rs8050136 polymorphism (3 studies/2404 cases and 5713 control subjects): fixed effect OR =1.25, 95%CI=1.13, 1.37, P heterogeneity=0.12, I2=51.9%. However, no significant association was found between genetics and risk of type 2 diabetes after control of potential confounders (at least for BMI) either for rs9939609 (fixed effect OR=1.05, 95% CI=0.97,1.13) or for rs8050136 polymorphism (fixed effect OR =1.07, 95%CI: 0.99, 1.16). Furthermore, the sensitivity analysis strengthened our confidence in validity of the association. Conclusion FTO polymorphisms are associated with obesity but not with type 2 diabetes in East Asian populations. Further large-scale studies are required to conclusively establish the association.
Authors: H Li; T O Kilpeläinen; C Liu; J Zhu; Y Liu; C Hu; Z Yang; W Zhang; W Bao; S Cha; Y Wu; T Yang; A Sekine; B Y Choi; C S Yajnik; D Zhou; F Takeuchi; K Yamamoto; J C Chan; K R Mani; L F Been; M Imamura; E Nakashima; N Lee; T Fujisawa; S Karasawa; W Wen; C V Joglekar; W Lu; Y Chang; Y Xiang; Y Gao; S Liu; Y Song; S H Kwak; H D Shin; K S Park; C H D Fall; J Y Kim; P C Sham; K S L Lam; W Zheng; X Shu; H Deng; H Ikegami; G V Krishnaveni; D K Sanghera; L Chuang; L Liu; R Hu; Y Kim; M Daimon; K Hotta; W Jia; J S Kooner; J C Chambers; G R Chandak; R C Ma; S Maeda; R Dorajoo; M Yokota; R Takayanagi; N Kato; X Lin; R J F Loos Journal: Diabetologia Date: 2011-11-23 Impact factor: 10.122
Authors: Carolina Ortega-Azorín; Jose V Sorlí; Eva M Asensio; Oscar Coltell; Miguel Ángel Martínez-González; Jordi Salas-Salvadó; Maria-Isabel Covas; Fernando Arós; José Lapetra; Lluís Serra-Majem; Enrique Gómez-Gracia; Miquel Fiol; Guillermo Sáez-Tormo; Xavier Pintó; Miguel Angel Muñoz; Emilio Ros; Jose M Ordovás; Ramon Estruch; Dolores Corella Journal: Cardiovasc Diabetol Date: 2012-11-06 Impact factor: 9.951
Authors: Bo Xi; Hong Cheng; Yue Shen; Giriraj R Chandak; Xiaoyuan Zhao; Dongqing Hou; Lijun Wu; Xingyu Wang; Jie Mi Journal: PLoS One Date: 2013-02-12 Impact factor: 3.240